In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avenue Therapeutics Inc.

Division of Fortress Biotech Inc.
www.avenuetx.com

Latest From Avenue Therapeutics Inc.

Cipla Propels 'Lung Leadership' Plans

Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.

Strategy Sales & Earnings

Cipla Propels Lung Leadership Plans, Reimagines Operating Models

Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.

Commercial Sales & Earnings

Cipla To Recalibrate US Investments

Cipla is to moderate investments across its US generics R&D and specialty business, while its India business components  prescription, trade generic and consumer health  are being brought under a “single capital allocation framework.”

Strategy Sales & Earnings

Cipla To Recalibrate US Investments, Partnering Plan For Specialty Business

Cipla to moderate investments across US generics R&D and specialty business, while its India business components - prescription, trade generic and consumer health - are being brought under a “single capital allocation framework.”

Commercial Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Fortress Biotech Inc.
  • Senior Management
  • Lucy Lu, MD, Pres. & CEO
    Joseph Vazzano, VP, Finance & Corp. Controller
  • Contact Info
  • Avenue Therapeutics Inc.
    2 Gansevoort St.
    9th Fl.
    New York, NY 10014
    USA
UsernamePublicRestriction

Register